OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Pulmonary Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	47
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	39
The persistent problem of persistent air-leaks: approach to management	33
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	31
Home monitoring in asthma: towards digital twins	30
Bronchoscopic treatment of early-stage peripheral lung cancer	30
The role of PET in the management of sarcoidosis	28
Improving care in lung cancer surgery: a review of quality measures and evolving standards	27
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	24
Digital outcome measures in pulmonary clinical trials	19
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	19
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	18
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	18
Implementation of digital home monitoring and management of respiratory disease	17
Group 2 pulmonary hypertension: from diagnosis to treatment	17
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	16
Considerations and clinical management of infections in sarcoidosis	16
Editorial introductions	15
Lung transplant referral considerations for individuals with cystic fibrosis	15
Editorial introductions	15
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	15
The future of clinical trials in idiopathic pulmonary fibrosis	14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	14

Asthma in pregnancy: a review of recent literature	14
Casting light on the many facets of sarcoidosis	14
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	14
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	13
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	13
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	13
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	13
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	13
Tobacco treatment in the setting of lung cancer screening	12
Imaging in peripheral bronchoscopy	12
Acute rejection post lung transplant	12
Progress for all: addressing disparities in sarcoidosis	12
Cystic fibrosis liver disease in the post-modulator era	12
Digital inhalers for asthma management	12
What causes cough in pulmonary fibrosis, and how should we treat it?	12
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	11
Home monitoring of coronavirus disease 2019 patients in different phases of disease	11
Editorial: Are we ready for prime time?	11
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	11
Novel insights in fibrotic pulmonary sarcoidosis	10
Exhaled breath analysis in interstitial lung disease	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	10
Effectiveness and safety of coronavirus disease 2019 vaccines	10
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	10
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	10
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	9
Altered pharmacology and toxicology during ageing: implications for lung disease	9
Multidisciplinary care in nonmalignant central airway obstruction	9
Epigenetics and aging: relevance for sleep medicine	9
Telerehabilitation in pulmonary diseases	9
Infection control in cystic fibrosis: evolving perspectives and challenges	9
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	9
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	9
Editorial: ‘What is your occupation?’: historical snippets	8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	8
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	8
Military deployment-related respiratory problems: an update	8
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	8
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	8
The changing landscape of infections in the lung transplant recipient	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Prader–Willi syndrome: an update	8
Approach to the hospitalized patient with pulmonary arterial hypertension	8
Right ventricular assessment in pulmonary hypertension	8
Adenotonsillectomy: the good, the bad and the unknown	8
Ergonomics in bronchoscopy	8
Advancements in airway stents: a comprehensive update	8
Long-term safety, durability of response, cessation and switching of biologics	8

Artificial intelligence for the optimal management of community-acquired pneumonia	7
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	7
Editorial introductions	7
Editorial introductions	7
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	7
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	7
Editorial introductions	7
Bronchoscopic lung volume reduction in emphysema: a review	7
Recent advances predict a bright future for nebulizers	7
Health inequities in the modulator era	7
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	7
Updates in the diagnosis and management of chronic thromboembolic disease	7
Methamphetamine-associated pulmonary arterial hypertension	7
Editorial: The role of ageing in pulmonary disease	6
Pulmonary alveolar proteinosis – current and future therapeutical strategies	6
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	6
Bronchoscopic interventions for chronic bronchitis	6
Interstitial lung disease following coronavirus disease 2019	6
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	6
Editorial introductions	6
Drug-resistant tuberculosis: advances in diagnosis and management	6
Role of biomarkers in lung nodule evaluation	6
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	6
Bacteriophages for bronchiectasis: treatment of the future?	6
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	6
Anesthetic considerations in interventional pulmonology	5
What is new in mediastinal staging?	5
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	5
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	5
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	5
Editorial introductions	5
Lung infections due to emerging fungal pathogens	5
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	5
Recent developments in occupational asthma	5
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	5
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	5
Indwelling pleural catheters for benign pleural effusions: a concise review	5
Environmental and occupational exposures in interstitial lung disease	5
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	5
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	5
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	4
Bedside to bench and back again-translational research in interventional pulmonology	4
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	4
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	4
COVID-19: vaccines, efficacy and effects on variants	4
Whole lung lavage: considerations from the anesthesiology perspective	4
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	4
Risk stratification of pulmonary embolism	4
Editorial introduction	4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	4
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	4
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	4
Management of complicated parapneumonic effusions	4
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	4
Editorial introductions	4
Sex differences in sleep and sleep-disordered breathing	3
The controversy over daylight saving time: evidence for and against	3
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	3
Glymphatic MRI techniques in sleep and neurodegenerative diseases	3
Lung transplantation: practical and important directions of care	3
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis	3
Senescence in pulmonary arterial hypertension: is there a link?	3
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	3
SMART - is it practical in the United States?	3
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	3
Vitamin D deficiency in chronic obstructive pulmonary disease	3
Progress and challenges in fungal lung disease in cystic fibrosis	3
Bronchodilator responsiveness in chronic obstructive pulmonary disease: prevalence, significance, and clinical implications	3
Keeping global focus on the many challenges of respiratory tract infections	3
Pregnancy and fertility in people with cystic fibrosis following lung transplantation	3
Leveraging AI technology in sarcoidosis	3
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	3
Ageing with Interstitial lung disease: preserving health and well being	3
Pulmonary adverse events following immune checkpoint inhibitors	3
Hit-hard and early versus step-up treatment in severe sarcoidosis	3
Update on the genetic basis of obstructive sleep apnoea – hype or hope?	3
Diversity and disparity in the treatment and care of sarcoidosis	3